內地電動車市場競爭加劇 傳日產及本田擬削減在中國產能
日本汽車大廠在中國市場正面對來自國產電動車廠的激烈競爭,據《日經亞洲》知悉,日產汽車及本田汽車正準備減少在中國產能。
報道指,日產未來數日將與中國合營展開討論,或削減中國產能最多30%,相當於每年50萬輛汽車。現時日產在中國產能達每年160萬輛。
日產現時透過與東風集團(00489.HK)的合營,在中國內地營運八間車廠,包括湖北及河南。日產將會重組其車廠產能,將部分產能轉用於向亞洲其他市場出口。日產去年在中國產出按年跌24%至79.3萬輛,屬十四年來首度跌穿100萬輛。
據報,本田亦計劃減少在中國產能約20%,公司正與中國夥伴討論,並已通知主要供應商將會減少產出。本田分別透過與廣汽集團(02238.HK)及東風的兩家合營,在中國每年總產能達149萬輛。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.